rivastigmine 1.5 MG Oral Capsule
1 INDICATIONS AND USAGE Rivastigmine tartrate capsules are an acetylcholinesterase inhibitor indicated for treatment of: Mild-to-moderate dementia of the Alzheimer’s type (AD) (1.1) Mild-to-moderate dementia associated with Parkinson’s disease (PD) (1.2) 1.1 Alzheimer’s Disease Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia of the Alzheimer's type (AD). 1.2 Parkinson’s Disease Dementia Rivastigmine tartrate capsules are indicated for the treatment of mild-to-moderate dementia associated with Parkinson’s disease (PD).
breckenridge pharmaceutical, inc
CAPSULE YELLOW B 793
Related Pills
rivastigmine 4.5 MG Oral Capsule
breckenridge pharmaceutical, inc
rivastigmine 3 MG Oral Capsule
breckenridge pharmaceutical, inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
RIVASTIGMINE TARTRATE capsules USP equivalent to 1.5 mg, 3 mg, 4.5 mg, or 6 mg of rivastigmine base are available as follows: 1.5 mg capsule – pale yellow opaque / pale yellow opaque size “2” hard gelatin capsules radially imprinted with “B” on cap and “793” on body with black ink, filled with white to off-white free flowing powder. Bottles of 30 NDC 51991-793-33 Bottles of 60 NDC 51991-793-06 Bottles of 500 NDC 51991-793-05 Bottles of 1000 NDC 51991-793-10 Unit Dose (blister pack) Box of 100 (strips of 10) NDC 51991-793-11 3 mg capsule – orange opaque / orange opaque size “2” hard gelatin capsules radially imprinted with “B” on cap and “794” on body with black ink, filled with white to off-white free flowing powder. Bottles of 30 NDC 51991-794-33 Bottles of 60 NDC 51991-794-06 Bottles of 500 NDC 51991-794-05 Bottles of 1000 NDC 51991-794-10 Unit Dose (blister pack) Box of 100 (strips of 10) NDC 51991-794-11 4.5 mg capsule – coral red opaque / coral red opaque size “2” hard gelatin capsules radially imprinted with “B” on cap and “795” on body with black ink, filled with white to off-white free flowing powder. Bottles of 30 NDC 51991-795-33 Bottles of 60 NDC 51991-795-06 Bottles of 500 NDC 51991-795-05 Bottles of 1000 NDC 51991-795-10 Unit Dose (blister pack) Box of 100 (strips of 10) NDC 51991-795-11 6 mg capsule – orange opaque / coral red opaque size “2” hard gelatin capsules radially imprinted with “B” on cap and “796” on body with black ink, filled with white to off-white free flowing powder. Bottles of 30 NDC 51991-796-33 Bottles of 60 NDC 51991-796-06 Bottles of 500 NDC 51991-796-05 Bottles of 1000 NDC 51991-796-10 Unit Dose (blister pack) Box of 100 (strips of 10) NDC 51991-796-11 Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store in a tight container.
More pills like CAPSULE B 793